Advertisement

Genetic Schizophrenia Risk Variants Jointly Modulate Total Brain and White Matter Volume

      Background

      Thousands of common single nucleotide polymorphisms (SNPs) are weakly associated with schizophrenia. It is likely that subsets of disease-associated SNPs are associated with distinct heritable disease-associated phenotypes. Therefore, we examined the shared genetic susceptibility modulating schizophrenia and brain volume.

      Methods

      Odds ratios for genome-wide SNP data were calculated in the sample collected by the Psychiatric Genome-wide Association Study Consortium (8690 schizophrenia patients and 11,831 control subjects, excluding subjects from the present study). These were used to calculate individual polygenic schizophrenia (risk) scores in an independent sample of 152 schizophrenia patients and 142 healthy control subjects with available structural magnetic resonance imaging scans.

      Results

      In the entire group, the polygenic schizophrenia score was significantly associated with total brain volume (R2=.048, p=1.6×10−4) and white matter volume (R2=.051, p=8.6×10−5) equally in patients and control subjects. The number of (independent) SNPs that substantially influenced both disease risk and white matter (n=2020) was much smaller than the entire set of SNPs that modulated disease status (n=14,751). From the set of 2020 SNPs, a group of 186 SNPs showed most evidence for association with white matter volume and an explorative functional analysis showed that these SNPs were located in genes with neuronal functions.

      Conclusions

      These results indicate that a relatively small subset of schizophrenia genetic risk variants is related to the (normal) development of white matter. This, in turn, suggests that disruptions in white matter growth increase the susceptibility to develop schizophrenia.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cardno A.G.
        • Marshall E.J.
        • Coid B.
        • Macdonald A.M.
        • Ribchester T.R.
        • Davies N.J.
        • et al.
        Heritability estimates for psychotic disorders: The Maudsley twin psychosis series.
        Arch Gen Psychiatry. 1999; 56: 162-168
        • Ripke S.
        • Sanders A.R.
        • Kendler K.S.
        • Levinson D.F.
        • Sklar P.
        • Holmans P.A.
        • et al.
        Genome-wide association study identifies five new schizophrenia loci.
        Nat Genet. 2011; 10: 969-976
        • Purcell S.M.
        • Wray N.R.
        • Stone J.L.
        • Visscher P.M.
        • O'donovan M.C.
        • Sullivan P.F.
        • et al.
        Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.
        Nature. 2009; 460: 748-752
        • Lee S.H.
        • Decandia T.R.
        • Ripke S.
        • Yang J.
        • Sullivan P.F.
        • Goddard M.E.
        • et al.
        Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs.
        Nat Genet. 2012; 44: 247-250
        • Gottesman I.I.
        • Gould T.D.
        The endophenotype concept in psychiatry: Etymology and strategic intentions.
        Am J Psychiatry. 2003; 160: 636-645
        • Hulshoff Pol H.E.
        • Schnack H.G.
        • Bertens M.G.
        • van Haren N.E.M.
        • van der Tweel I.
        • Staal W.G.
        • et al.
        Volume changes in gray matter in patients with schizophrenia.
        Am J Psychiatry. 2002; 159: 244-250
        • Wright I.C.
        • Rabe-Hesketh S.
        • Woodruff P.W.
        • David A.S.
        • Murray R.M.
        • Bullmore E.T.
        Meta-analysis of regional brain volumes in schizophrenia.
        Am J Psychiatry. 2000; 157: 16-25
        • Baare W.F.
        • Hulshoff Pol H.E.
        • Boomsma D.I.
        • Posthuma D.
        • De Geus E.J.
        • Schnack H.G.
        • et al.
        Quantitative genetic modeling of variation in human brain morphology.
        Cereb Cortex. 2001; 11: 816-824
        • Cannon T.D.
        • Thompson P.M.
        • van Erp T.G.
        • Toga A.W.
        • Poutanen V.P.
        • Huttunen M.
        • et al.
        Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia.
        Proc Natl Acad Sci U S A. 2002; 99: 3228-3233
        • Goldman A.L.
        • Pezawas L.
        • Mattay V.S.
        • Fischl B.
        • Verchinski B.A.
        • Zoltick B.
        • et al.
        Heritability of brain morphology related to schizophrenia: A large-scale automated magnetic resonance imaging segmentation study.
        Biol Psychiatry. 2008; 63: 475-483
        • van Haren N.E.
        • Rijsdijk F.
        • Schnack H.G.
        • Picchioni M.M.
        • Toulopoulou T.
        • Weisbrod M.
        • et al.
        The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: The schizophrenia twins and relatives consortium.
        Biol Psychiatry. 2012; 71: 915-921
        • Boos H.B.
        • Aleman A.
        • Cahn W.
        • Hulshoff Pol H.E.
        • Kahn R.S.
        Brain volumes in relatives of patients with schizophrenia: A meta-analysis.
        Arch Gen Psychiatry. 2007; 64: 297-304
        • Genetic Risk and Outcome in Psychosis (GROUP) Investigators
        Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: An analysis of patient-sibling and sibling-control pairs.
        Arch Gen Psychiatry. 2011; 68: 138-147
        • van Haren N.E.
        • Hulshoff Pol H.E.
        • Schnack H.G.
        • Cahn W.
        • Brans R.
        • Carati I.
        • et al.
        Progressive brain volume loss in schizophrenia over the course of the illness: Evidence of maturational abnormalities in early adulthood.
        Biol Psychiatry. 2008; 63: 106-113
        • Andreasen N.C.
        • Flaum M.
        • Arndt S.
        The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.
        Arch Gen Psychiatry. 1992; 49: 615-623
        • Boos H.B.
        • Cahn W.
        • van Haren N.E.
        • Derks E.M.
        • Brouwer R.M.
        • Schnack H.G.
        • et al.
        Focal and global brain measurements in siblings of patients with schizophrenia.
        Schizophr Bull. 2011; 38: 814-825
        • Sled J.G.
        • Zijdenbos A.P.
        • Evans A.C.
        A nonparametric method for automatic correction of intensity nonuniformity in MRI data.
        IEEE Trans Med Imaging. 1998; 17: 87-97
        • Brouwer R.M.
        • Hulshoff Pol H.E.
        • Schnack H.G.
        Segmentation of MRI brain scans using non-uniform partial volume densities.
        Neuroimage. 2010; 49: 467-477
        • Purcell S.
        • Neale B.
        • Todd-Brown K.
        • Thomas L.
        • Ferreira M.A.
        • Bender D.
        • et al.
        PLINK: A tool set for whole-genome association and population-based linkage analyses.
        Am J Hum Genet. 2007; 81: 559-575
        • Courchesne E.
        • Chisum H.J.
        • Townsend J.
        • Cowles A.
        • Covington J.
        • Egaas B.
        • et al.
        Normal brain development and aging: Quantitative analysis at in vivo MR imaging in healthy volunteers.
        Radiology. 2000; 216: 672-682
        • Buizer-Voskamp J.E.
        • Muntjewerff J.W.
        • Strengman E.
        • Sabatti C.
        • Stefansson H.
        • Vorstman J.A.
        • et al.
        Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients.
        Biol Psychiatry. 2011; 70: 655-662
        • Wei Huang D.
        • Sherman B.T.
        • Lempicki R.A.
        Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
        Nat Protoc. 2009; 4: 44-57
        • Takahashi N.
        • Sakurai T.
        • Davis K.L.
        • Buxbaum J.D.
        Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.
        Prog Neurobiol. 2011; 93: 13-24
        • Connor C.M.
        • Crawford B.C.
        • Akbarian S.
        White matter neuron alterations in schizophrenia and related disorders.
        Int J Dev Neurosci. 2011; 29: 325-334
        • van den Heuvel M.P.
        • Kahn R.S.
        Abnormal brain wiring as a pathogenetic mechanism in schizophrenia.
        Biol Psychiatry. 2011; 70: 1107-1108
        • Moncrieff J.
        • Leo J.
        A systematic review of the effects of antipsychotic drugs on brain volume.
        Psychol Med. 2010; 40: 1409-1422
        • Elbers C.C.
        • van Eijk K.R.
        • Franke L.
        • Mulder F.
        • van der Schouw Y.T.
        • Wijmenga C.
        • Onland-Moret N.C.
        Using genome-wide pathway analysis to unravel the etiology of complex diseases.
        Genet Epidemiol. 2009; 33: 419-431
        • Fabre P.J.
        • Shimogori T.
        • Charron F.
        Segregation of ipsilateral retinal ganglion cell axons at the optic chiasm requires the Shh receptor Boc.
        J Neurosci. 2010; 30: 266-275
        • Behan A.T.
        • Byrne C.
        • Dunn M.J.
        • Cagney G.
        • Cotter D.R.
        Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
        Mol Psychiatry. 2009; 14: 601-613
        • Cottrell C.E.
        • Bir N.
        • Varga E.
        • Alvarez C.E.
        • Bouyain S.
        • Zernzach R.
        • et al.
        Contactin 4 as an autism susceptibility locus.
        Autism Res. 2011; 4: 189-199
        • Wang K.
        • Zhang H.
        • Bloss C.S.
        • Duvvuri V.
        • Kaye W.
        • Schork N.J.
        • et al.
        A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa.
        Mol Psychiatry. 2011; 16: 949-959
        • Kegeles L.S.
        • Mao X.
        • Stanford A.D.
        • Girgis R.
        • Ojeil N.
        • Xu X.
        • et al.
        Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
        Arch Gen Psychiatry. 2012; 69: 449-459